Tamer Mohamed
Featured
Aspect Biosystems Strikes $2.6B Bioprinted Tissue Deal with Novo Nordisk
Bioprinting collaborations are heating up in 2023. In one of the biggest moves of the bioprinting industry, Canadian startup Aspect Biosystems and Danish pharma giant Novo Nordisk (CPH: NOVO-B) struck…
Aspect Biosystems Partners With JDRF to Treat Diabetes
Canadian biotech startup Aspect Biosystems, founded and led by biomedical engineer Tamer Mohamed, has partnered with the nonprofit organization Juvenile Diabetes Research Foundation (JDRF) to develop bioengineered tissue therapeutics to…
Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics
While attending The University of British Columbia (UBC), Tamer Mohamed, along with fellow graduate student Simon Beyer, began working at the Walus Laboratory on the development of a novel microfluidics-based…
